Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- Check4 days agoChange DetectedThe history shows a new Revision: v3.3.4 added and v3.3.3 removed, indicating a small maintenance update to the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedFooter updates add Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. This appears to be a backend version update with no visible changes to study records or navigation.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page shows a system update: Revision: v3.3.1 was added and Revision: v3.2.0 was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedThe notice about government funding and site operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedThe old and new screenshots show a cosmetic update to the Record History page without changes to the actual study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.